There were 2,053 press releases posted in the last 24 hours and 393,940 in the last 365 days.

Global Tissue Diagnostics Market Growth, Company Profiles, Size, Recent Developments, Investments and Forecasts to 2027



PUNE, MAHARASHTRA, INDIA, July 5, 2022 / -- The global Tissue Diagnostics Market is growing at a CAGR of 6.6% during and it is expected to reach USD 7.3 billion by 2027 from USD 5.3 billion in 2022, during the forecast period. The expansion of this market is majorly due to rising prevalence of neoplastic cases as well as the high demand of oncology screening, However, the Lack of skilled professionals is one of the challenges for which may inhibit the growth of this market.

“The Slide-Staining Systems in instruments is projected to grow at CAGR of 7.4% from 2022 to 2027”
Based on the product, the tissue diagnostics market is classified into tissue diagnostics consumables (Antibodies, Kits, Reagents, Probes) and tissue diagnostics Instruments (Slide-staining Systems, Scanners, Tissue-processing Systems, and Other Instruments). The growth of this market is majorly driven by the factors such as the benefits of automation, the greater capacity of slide staining systems, the elimination of manual errors, and delivering high throughput staining capabilities for histology laboratories.

Get a Free Sample Copy of the Global Tissue Diagnostics Market Research Report at

“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the tissue diagnostics market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the economic growth in the countries of this region, large population base, the rising prevalence of chronic diseases, the rising standard of living, growing demand for quality medical care, increasing healthcare spending, increasing government initiatives, and rising awareness regarding the use of tissue diagnostic tests.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (32%), Tier 2(44%), and Tier 3 (24%)
• By Designation: C-level (30%), Director-level (34%), and Others (36%)
• By Region: North America (40%), Europe (28%), Asia Pacific (20%), and the Rest of the World (12%)

List of Companies Profiled in the Report
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Danaher Corporation (US)
• Thermo Fisher Scientific, Inc (US)
• Abbott (US)
• Agilent Technologies Inc. (US)
• Merck KGAA (Germany)
• Abcam Plc. (UK)
• Becton, Dickinson and Company (BD) (US)
• Bio SB (US)
• Biogenix (US)
• Cell Signaling Technology, Inc (US)
• Histo-Line Laboratories (Italy)
• SLEE Medical GMBH (Germany)
• Hologic Inc. (US).
• Jinhua YIDI Medical Appliance Co. Ltd (China)
• Cellpath Ltd (UK)
• Amos scientific Pty Ltd (Australia)
• Dipath S.P.A (Italy)
• LTD (China), Diagnostic BioSystems Inc. (US)
• 3DHISTECH LTD (Hungary)
• Dakewe Biotech Co., Ltd. (China)

Direct Purchase of the Global Tissue Diagnostics Market Research Report at

Research Coverage:
This report studies the tissue diagnostics market based on product, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total tissue diagnostics market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on tissue diagnostics products offered by the top 25 players in the tissue diagnostics market. The report analyzes the tissue diagnostics market by product and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the tissue diagnostics market
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the tissue diagnostics market.

Ganesh Pardeshi
+1 888 391 5441